IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 24 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $181,353 | -49.9% | 99,100 | -19.0% | 0.00% | – |
Q2 2023 | $362,008 | -16.0% | 122,300 | -21.4% | 0.00% | – |
Q1 2023 | $430,765 | -74.4% | 155,511 | -51.1% | 0.00% | – |
Q4 2022 | $1,684,467 | +81.9% | 317,824 | +36.9% | 0.00% | – |
Q3 2022 | $926,000 | +5.1% | 232,238 | +1.8% | 0.00% | – |
Q2 2022 | $881,000 | -9.9% | 228,200 | +20.0% | 0.00% | – |
Q1 2022 | $978,000 | -54.1% | 190,188 | -52.2% | 0.00% | – |
Q4 2021 | $2,132,000 | +6.5% | 397,570 | +23.6% | 0.00% | – |
Q3 2021 | $2,001,000 | +1084.0% | 321,705 | +1768.3% | 0.00% | – |
Q1 2021 | $169,000 | – | 17,219 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 396,425 | $5,927,000 | 0.29% |
Gradient Capital Advisors, LLC | 21,718 | $325,000 | 0.18% |
Hillsdale Investment Management Inc. | 15,200 | $232,000 | 0.02% |
Orion Portfolio Solutions, LLC | 15,821 | $237,000 | 0.01% |
IFP Advisors, Inc | 1,960 | $30,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 300 | $4,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
CITIGROUP INC | 7 | $0 | 0.00% |
MORGAN STANLEY | 2,100 | $31,000 | 0.00% |
BANK OF MONTREAL /CAN/ | 5,900 | $98,000 | 0.00% |